Zafgen is a biopharmaceutical company focused on improving the health and well-being of patients affected by both rare and prevalent metabolic diseases including type 2 diabetes, Prader-Willi syndrome and other metabolically related disorders. The company is focused on developing therapeutics that treat biological mechanisms through the MetAP2 pathway. The company's primary product candidate is ZGN-1061, a fumagillin-class MetAP2 inhibitor administered by subcutaneous injection, which is being profiled for its utility in the treatment of type 2 diabetes. The company also has initiated development of a second, MetAP2 development candidate, ZGN-1258, administered by subcutaneous injection.
  • TickerZFGN
  • ISINUS98885E1038
  • ExchangeNASDAQ Stock Market
  • SectorPharmaceuticals & Biotechnology
  • CountryUnited States

Analysts

ValuEngine Rating and Forecast Report for ZFGN

ValuEngine Rating and Forecast Report for ZFGN

Liana Moussatos ...
  • Shveta Dighe

Q1 Financials; Updates on ZGN-1061/T2D Clinical Hold Anticipated in Q2

Liana Moussatos ...
  • Shveta Dighe

Q1 Financials; Updates on ZGN-1061/T2D Clinical Hold Anticipated in Q2

A director bought 10,000 shares at 3.390USD and

A director at Zafgen Inc bought 10,000 shares at 3.390USD and the significance rating of the trade was 64/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing Close periods where trading activity is restricted under listing rules. The names of bo...

ValuEngine Rating and Forecast Report for ZFGN

ValuEngine Rating and Forecast Report for ZFGN

ValuEngine Rating and Forecast Report for ZFGN

ValuEngine Rating and Forecast Report for ZFGN

ValuEngine Rating and Forecast Report for ZFGN

ValuEngine Rating and Forecast Report for ZFGN

ValuEngine Rating and Forecast Report for ZFGN

ValuEngine Rating and Forecast Report for ZFGN

ValuEngine Rating and Forecast Report for ZFGN

ValuEngine Rating and Forecast Report for ZFGN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch